TABLE 2.

Clinical outcomes after A2 incompatible kidney transplantation

Clinical outcomes	A2 incompatible transplant, N =41	Blood group compatible transplant, N = 75	P
Patient survival	100%	91%	0.050
Graft survival	92%	92%	0.99
Acute rejection
T-cell–mediated rejection	2 (5%)	3 (4%)
Antibody-mediated rejection	0	1 (1.3%)
Chronic antibody-mediated rejection	1 (2%)	1 (1.3%)
Serum creatinine at the last visit, median (range) mg/dL	1.3 (0.6–3.2)	1.35 (0.4–7.0)	0.74
Spot urine protein/creatinine at the last clinic visit, median (range]) g/g	0.16 (0–2.4)	0.19 (0.05–7.9)	0.22
Spot urine protein/creatinine > 1 g/g	3 (7%)	11 (15%)
Cytomegalovirus viremia	6 (15%)	11 (15%)	0.99
BK viremia	9 (22%)	15 (20%)	0.80
Urinary tract infections	15 (37%)	37 (49%)	0.19
Pneumonia	14 (34%)	13 (17%)	0.041
Influenza	3 (7%)	14 (19%)	0.10